Functional differences between Hsp105/110 family proteins in cell proliferation, cell division, and drug sensitivity.


Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
12 2021
Historique:
revised: 08 09 2021
received: 31 03 2021
accepted: 16 09 2021
pubmed: 8 10 2021
medline: 15 3 2022
entrez: 7 10 2021
Statut: ppublish

Résumé

The mammalian HSP105/110 family consists of four members, including Hsp105 and Apg-1, which function as molecular chaperones. Recently, we reported that Hsp105 knockdown increases sensitivity to the DNA-damaging agent Adriamycin but decreases sensitivity to the microtubule-targeting agent paclitaxel. However, whether the other Hsp105/110 family proteins have the same functional property is unknown. Here, we show that Apg-1 has different roles from Hsp105 in cell proliferation, cell division, and drug sensitivity. We generated the Apg-1-knockdown HeLa S3 cells by lentiviral expression of Apg-1-targeting short hairpin RNA. Knockdown of Apg-1 but not Hsp105 decreased cell proliferation. Apg-1 knockdown increased cell death upon Adriamycin treatment without affecting paclitaxel sensitivity. The cell synchronization experiment suggests that Apg-1 functions in mitotic progression at a different mitotic subphase from Hsp105, which cause difference in paclitaxel sensitivity. Since Apg-1 is overexpressed in certain types of tumors, Apg-1 may become a potential therapeutic target for cancer treatment without causing resistance to the microtubule-targeting agents.

Identifiants

pubmed: 34617313
doi: 10.1002/jcb.30158
doi:

Substances chimiques

HSP110 Heat-Shock Proteins 0
HSPH1 protein, human 0
Neoplasm Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1958-1967

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Richter K, Haslbeck M, Buchner J. The heat shock response: life on the verge of death. Mol Cell. 2010;40:253-266. doi:10.1016/j.molcel.2010.10.006
Easton DP, Kaneko Y, Subjeck JR. The Hsp110 and Grp170 stress proteins: newly recognized relatives of the Hsp70s. Cell Stress Chaperones. 2000;5(4):276-290. doi:10.1379/1466-1268(2000)0052.0.CO;2, doi:10.1379/1466-1268(2000)005%3C0276:thagsp%3E2.0.co;2
Kampinga HH, Hageman J, Vos MJ, et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14:105-111. doi:10.1007/s12192-008-0068-7
Serlidaki D, van Waarde M, Rohland L, et al. Functional diversity between HSP70 paralogs caused by variable interactions with specific co-chaperones. J Biol Chem. 2020;295:7301-7316. doi:10.1074/jbc.RA119.012449
Bracher A, Verghese J. The nucleotide exchange factors of Hsp70 molecular chaperones. Front Mol Biosci. 2015;78:1-33. doi:10.1007/978-3-319-11731-7_1
Nillegoda NB, Bukau B. Metazoan Hsp70-based protein disaggregases: emergence and mechanisms. Front Mol Biosci. 2015;2:57. doi:10.3389/fmolb.2015.00057
Yasuda K, Nakai A, Hatayama T, Nagata K. Cloning and expression of murine high molecular mass heat shock proteins, HSP105. J Biol Chem. 1995;270:29718-29723. doi:10.1074/jbc.270.50.29718
Ishihara K, Yasuda K, Hatayama T. Molecular cloning, expression and localization of human 105 kDa heat shock protein, hsp105. Biochim Biophys Acta. 1999;1444:138-142. doi:10.1016/S0167-4781(98)00254-1
Lee-Yoon D, Easton D, Murawski M, Burd R, Subjeck JR. Identification of a major subfamily of large hsp70-like proteins through the cloning of the mammalian 110-kDa heat shock protein. J Biol Chem. 1995;270:15725-15733. doi:10.1074/jbc.270.26.15725
Yamagishi N, Ishihara K, Saito Y, Hatayama T. Hsp105 family proteins suppress staurosporine-induced apoptosis by inhibiting the translocation of Bax to mitochondria in HeLa cells. Exp Cell Res. 2006;312:3215-3223. doi:10.1016/j.yexcr.2006.06.007
Yamagishi N, Saito Y, Hatayama T. Mammalian 105 kDa heat shock family proteins suppress hydrogen peroxide-induced apoptosis through a p38 MAPK-dependent mitochondrial pathway in HeLa cells. FEBS J. 2008;275:4558-4570. doi:10.1111/j.1742-4658.2008.06598.x
Kai M, Nakatsura T, Egami H, Senju S, Nishimura Y, Ogawa M. Heat shock protein 105 is overexpressed in a variety of human tumors. Oncol Rep. 2003;10:1777-1782. doi:10.3892/or.10.6.1777
Nakatsura T, Senju S, Yamada K, Jotsuka T, Ogawa M, Nishimura Y. Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. Biochem Biophys Res Commun. 2001;281:936-944. doi:10.1006/bbrc.2001.4377
Hosaka S, Nakatsura T, Tsukamoto H, Hatayama T, Baba H, Nishimura Y. Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo. Cancer Sci. 2006;97:623-632. doi:10.1111/j.1349-7006.2006.00217.x
Yamane T, Saito Y, Teshima H, et al. Hsp105α suppresses Adriamycin-induced cell death via nuclear localization signal-dependent nuclear accumulation. J Cell Biochem. 2019;120:17951-17962. doi:10.1002/jcb.29062
Causse SZ, Marcion G, Chanteloup G, et al. HSP110 translocates to the nucleus upon genotoxic chemotherapy and promotes DNA repair in colorectal cancer cells. Oncogene. 2019;38:2767-2777. doi:10.1038/s41388-018-0616-2
Kakihana A, Oto Y, Saito Y, Nakayama Y. Heat shock-induced mitotic arrest requires heat shock protein 105 for the activation of spindle assembly checkpoint. FASEB J. 2019;33:3936-3953. doi:10.1096/fj.201801369R
Kaneko Y, Nishiyama H, Nonoguchi K, Higashitsuji H, Kishishita M, Fujita J. A novel hsp110-related gene, apg-1, that is abundantly expressed in the testis responds to a low temperature heat shock rather than the traditional elevated temperatures. J Biol Chem. 1997;272:2640-2645. doi:10.1074/jbc.272.5.2640
Held T, Paprotta I, Khulan J, et al. Hspa4l-deficient mice display increased incidence of male infertility and hydronephrosis development. Mol Cell Biol. 2006;26:8099-8108. doi:10.1128/mcb.01332-06
Stewart SA, Dykxhoorn DM, Palliser D, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 2003;9:493-501. doi:10.1261/rna.2192803
Saharia A, Guittat L, Crocker S, et al. Flap endonuclease 1 contributes to telomere stability. Curr Biol. 2008;18:496-500. doi:10.1016/j.cub.2008.02.071
Nakayama Y, Saito Y, Soeda S, et al. Genistein induces cytokinesis failure through RhoA delocalization and anaphase chromosome bridging. J Cell Biochem. 2014;115:763-771. doi:10.1002/jcb.24720
Okumura D, Hagino M, Yamagishi A, et al. Inhibitors of the VEGF receptor suppress HeLa S3 cell proliferation via misalignment of chromosomes and rotation of the mitotic spindle, causing a delay in M-phase progression. Int J Mol Sci. 2018;19(12):4012. doi:10.3390/ijms19124014
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452-458. doi:10.1038/bmt.2012.244
Wang S, Mo Y, Midorikawa K, et al. The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget. 2015;6:35893-35907. doi:10.18632/oncotarget.5651
Berthenet K, Bokhari A, Lagrange A, et al. HSP110 promotes colorectal cancer growth through STAT3 activation. Oncogene. 2017;36:2328-2336. doi:10.1038/onc.2016.403
Zappasodi R, Ruggiero G, Guarnotta C, et al. HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma. Blood. 2015;125:1768-1771. doi:10.1182/blood-2014-07-590034
Backe SJ, Sager RA, Woodford MR, Makedon AM, Mollapour M. Post-translational modifications of Hsp90 and translating the chaperone code. J Biol Chem. 2020;295:11099-11117. doi:10.1074/jbc.REV120.011833
NitikaPorter CM, Truman AW, Truttmann MC. Post-translational modifications of Hsp70 family proteins: expanding the chaperone code. J Biol Chem. 2020;295:10689-10708. doi:10.1074/jbc.REV120.011666
Saito Y, Yamagishi N, Hatayama T. Different localization of Hsp105 family proteins in mammalian cells. Exp Cell Res. 2007;313:3707-3717. doi:10.1016/j.yexcr.2007.06.009
Saito Y, Yamagishi N, Hatayama T. Nuclear localization mechanism of Hsp105β and its possible function in mammalian. J Biochem. 2009;145185-191. doi:10.1093/jb/mvn155
Chakafana G, Shonhai A. The role of non-canonical Hsp70s (Hsp110/Grp170) in cancer. Cells. 2021;10:254. doi:10.3390/cells10020254
Gascoigne KE, Taylor SS. How do anti-mitotic drugs kill cancer cells? J Cell Sci. 2009;122:2579-2585. doi:10.1242/jcs.039719
Takahashi H, Furukawa T, Yano T, et al. Identification of an overexpressed gene, HSPA4L, the product of which can provoke prevalent humoral immune responses in leukemia patients. Exp Hematol. 2007;35:1091-1099. doi:10.1016/j.exphem.2007.03.015
Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98-W102. doi:10.1093/nar/gkx247
Fekete JT, Győrffy B. ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer. 2019;145:3140-3151. doi:10.1002/ijc.32369
Wang Y, Wang J, Yang L, et al. Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy. Nanomedicine. 2019;21:102066. doi:10.1016/j.nano.2019.102066
Čermák V, Dostál V, Jelínek M, et al. Microtubule-targeting agents and their impact on cancer treatment. Eur J Cell Biol. 2020;99:151075. doi:10.1016/j.ejcb.2020.151075

Auteurs

Hiroko Teshima (H)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Hiroko Watanabe (H)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Ryuji Yasutake (R)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Yuki Ikeda (Y)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Yukiko Yonezu (Y)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Namiko Okamoto (N)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Ayana Kakihana (A)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Ryuzaburo Yuki (R)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Yuji Nakayama (Y)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Youhei Saito (Y)

Department of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH